By: Benzinga
Elan Board Issues Response to Earlier Royalty Pharma Statement
The Board of Elan Corporation, plc (NYSE: ELN ) (the Company) acknowledges this morning's statement by Royalty Management, LLC (Royalty Pharma). Elan's position remains as outlined on February 25, 2013: * The “proposal” by Royalty Pharma remains an indication of interest, is highly conditional and may or may
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here